Clearsense

ClearsenseClearsense
C

Clearsense

Clearsense is a healthcare data platform that increases data value, governance, and transparency for health systems.

DR 332015Active96Jacksonville, United States
Rate

About

Clearsense offers an enterprise healthcare data platform designed to unify disparate data sources into a centralized view. Their solutions, including Active Data Archiving and a Healthcare Data Lakehouse, enable healthcare organizations to maximize cost savings, increase revenue, and accelerate research. Clearsense serves hospitals and healthcare systems by providing a scalable, cloud-native platform for data enablement.
Frequently asked

What does Clearsense do?

Clearsense offers an enterprise healthcare data platform designed to unify disparate data sources into a centralized view. Their solutions, including Active Data Archiving and a Healthcare Data Lakehouse, enable healthcare organizations to maximize cost savings, increase revenue, and accelerate research. Clearsense serves hospitals and healthcare systems by providing a scalable, cloud-native platform for data enablement.

What is Clearsense's revenue?

StartupHub estimates Clearsense's annual revenue at $17.6M (range $9.8M to $21.2M, 66% confidence), based on comparable companies in the sector.

What is Clearsense's valuation?

StartupHub estimates Clearsense's effective valuation at $99.2M (range $69.4M to $129.0M, 28% confidence), based on comparable companies in the sector.

How much funding has Clearsense raised?

Clearsense has raised a total of $50M in funding. The most recent round on record is Series D.

Where is Clearsense headquartered?

Clearsense is headquartered in Jacksonville, United States.

When was Clearsense founded?

Clearsense was founded in 2015.

What industry does Clearsense operate in?

Clearsense operates in Healthcare, Data Analytics, SaaS, PaaS, Big Data, Data Management.

How many employees does Clearsense have?

Clearsense has approximately 96 people on record.

HEADCOUNT
96
DOMAIN RATING
33
Comments

No comments yet. Be the first to share your take.